Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/14/17 | 8-K | Current report filing |
|
40 | |
| 08/14/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
74 |
| 08/09/17 | 8-K | Current report filing |
|
11 | |
| 08/09/17 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
6 | |
| 06/30/17 | SC 13D | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
108 | |
| 06/16/17 | 25-NSE | Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
|
2 | |
| 06/15/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/12/17 | 8-K | Current report filing |
|
4 | |
| 06/06/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/02/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
